003520.KS
Yungjin Pharm. Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 1,112.00
−0.98%Margins
Gross margin
29.0%
EBITDA margin
1.8%
EBIT margin
-1.7%
Net margin
-2.5%
FCF margin
-3.3%
-7.3%
Return on equity
-2.8%
Return on assets
-2.7%
Return on invested capital
1.10x
Asset turnover
-KRW 2.9B
Cash from operations
KRW 20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026